Yonsu Son

Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance

Rheumatoid arthritis

IDO-expressing regulatory dendritic cells in cancer and chronic infection

Cushing's syndrome

Pharmacologic Management of Cushing Syndrome

Aberrant Expression of Hormone Receptors in Adrenal Cushing's Syndrome

Cushing's syndrome variants secondary to aberrant hormone receptors

ACTH-independent macronodular adrenocortical hyperplasia reveals prevalent aberrant in vivo and in vitro responses to hormonal stimuli and coupling of arginine-vasopressin type 1a receptor to 11β-hydroxylase

ACTH-independent macronodular adrenal hyperplasia

The IL-6 feed-forward loop: A driver of tumorigenesis

Cushing's syndrome

Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond

New therapeutic perspectives to manage refractory immune checkpoint-related toxicities

Aberrant G‐protein coupled receptor expression in relation to adrenocortical overfunction

NF-κB, inflammation, immunity and cancer: coming of age

Aberrant cortisol regulations in bilateral macronodular adrenal hyperplasia: a frequent finding in a prospective study of 32 patients with overt or subclinical Cushing's syndrome

Frequency and significance of parvovirus B19 infection in patients with rheumatoid arthritis

In Vivo and in Vitro Screening for Illegitimate Receptors in Adrenocorticotropin-Independent Macronodular Adrenal Hyperplasia Causing Cushing’s Syndrome: Identification of Two Cases of Gonadotropin/Gastric Inhibitory Polypeptide-Dependent Hypercortisolism

Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors

Serum Interleukin 6 Before and After Therapy with Tocilizumab Is a Principal Biomarker in Patients with Rheumatoid Arthritis

Case of Adrenocorticotropic Hormone-Independent

Prostaglandin E₂ is a negative regulator on human plasmacytoid dendritic cells